Life Sciences Insights

Sharing expert knowledge via our latest blog posts

Elevate Pharma Imports with EU GMP Annexes 16 and 21

Discover how EU GMP Annexes 16 and 21 enhance pharmaceutical import quality and safety. Learn about their global impact on public health.

In the world of pharma imports, maintaining Good Manufacturing Practice (GMP) standards is a shared responsibility that transcends borders.

The European Union (EU) stands at the forefront of this commitment, with two key regulatory documents underpinning the EU’s dedication to pharmaceutical quality and safety: Annex 16 and Annex 21.

These annexes provide the framework for achieving and maintaining GMP compliance in the complex landscape of pharma imports.

GMP Annex 16: Raising the Certification Bar

Annex 16 of the EU GMP guidelines is crucial for ensuring the quality of imported pharmaceutical batches.

This annex focuses on the responsibilities of qualified persons (QPs) and mandates a meticulous certification process to verify compliance with GMP standards.

The result is impeccable quality that aligns with the EU’s rigorous benchmarks, ensuring that only the best products reach consumers.

GMP Annex 21: Tackling Import Challenges

GMP Annex 21 guides the importation of pharmaceutical products, covering active substances, finished products, and investigational medicinal products.

This comprehensive document addresses every aspect of the import process, from documentation to transportation.

Annex 21 ensures that practices are synchronized, promoting consistent regulatory harmony across the industry.

Uniting on the Global Stage

The EU’s efforts extend beyond its borders. GMP annexes 16 and 21 resonate globally, aligning with international standards set by organizations like the International Council for Harmonisation (ICH) and the World Health Organization (WHO).

The goal is to ensure that quality and safety are upheld in pharmaceutical imports, regardless of their origin.

Elevating Public Health

At their core, these annexes are about more than just regulations—they are about protecting public health. By maintaining unwavering standards, the EU fosters consumer confidence and nurtures a cohesive, global pharmaceutical ecosystem. These efforts ensure that every imported product meets the highest standards of quality and safety.

Do you want help making pharmaceutical imports easier and more reliable?

Quercus provides expert guidance and comprehensive solutions to help you adhere to EU GMP standards and learn how we can support your pharmaceutical quality and compliance needs.

Did you find this article interesting? Thanks for sharing it with your network:

Subscribe to the Blog
Here you will find interesting articles and news related to your industry.

Table of Contents

Stay up to date with the latest in life sciences

Come visit our booth at CPHI Barcelona 2023

Come to see the QbD Group at stand #3G73 at CPHI Conference in Barcelona. And after the conference…Eat & Connect with lifescience professionals at our QbD’s CPHI Networking Drink.